00703-7239 Ondansetron and Dextrose - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00703-7239

Brand Name:

Ondansetron and Dextrose

Generic Name:

Ondansetron and Dextrose

Dosage Form Name:

Injection

Administration Route:

Intramuscular

Intravenous

Substances:

Packages:

Code: 00703-7239-31

Description:

Effective Date: Nov. 22, 2006

Discontinued: March 31, 2011

Code: 00703-7239-39

Description:

Effective Date: Nov. 22, 2006

Discontinued: March 31, 2011

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used